Global monitoring studies to track changes in resistance profiles over time through the yearly collection of thousands of bacterial and fungal isolates tested against new candidate compounds and marketed antimicrobial agents. Utilized to support new drug approval submissions as well as phase IV post-marketing support programs.
Author medical publications (reports / abstracts / posters / manuscripts) for companies to utilize this information in pursuit of new drug applications and / or to publish the testing results to the scientific community.
